Politiparty
Politiparty

118th Congress Health

H.R. 4438: John W. Walsh Alpha-1 Home Infusion Act of 2023

Introduced

  1. Introduced (completed)Jun 30, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Jun 30, 2023

This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

59

Bipartisan support.

Who scored on this bill

18 points earned
  1. 1Maria Salazar R-FL SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone4 events+18
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Maria Salazar

History

  1. Jun 30, 2023Introduced in the House by Maria Salazar.
Show the full action history (4 actions)
  1. Dec 17, 2024Referred to the Subcommittee on Health.
  2. Jul 7, 2023Referred to the Subcommittee on Health.
  3. Jun 30, 2023Introduced in House
  4. Jun 30, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.